Vaccine-preventable diseases in Europe: where do we stand?

  title={Vaccine-preventable diseases in Europe: where do we stand?},
  author={Sabine Wicker and Helena C. Maltezou},
  journal={Expert Review of Vaccines},
  pages={979 - 987}
During the second half of the 20th century, vaccinations led to the control or even eradication of several vaccine-preventable diseases (VPDs) in Europe. However, outbreaks of VPDs continue to occur even in countries with well-established vaccination programs. Reasons include the existence of under-vaccinated populations, the increasing anti-vaccination movement and the increasing movement of populations across borders. Ensuring adequate levels of herd immunity is the only reliable method for… 

Mandatory vaccination: suited to enhance vaccination coverage in Europe?

  • H. HolzmannU. Wiedermann
  • Medicine, Political Science
    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
  • 2019
Vaccines are one of the most successful medical measures that save millions of human lives every year but vaccination coverages against highly contagious pathogens such as measles virus are not sufficient to prevent outbreaks and infectious disease spread in many countries today.

Challenges for nationwide vaccine delivery in African countries

  • M. Songane
  • Political Science
    International Journal of Health Economics and Management
  • 2017
The role of philanthropic organisations such as the Bill and Melinda Gates Foundation and global partnershipssuch as the global alliance for vaccines and immunizations in the development, purchase and delivery of vaccines are discussed.

Incidence of Vaccine Preventable Diseases in Pediatric Population of Latvia

As vaccine preventable diseases become less common and parents have little familiarity with the devastating effects of vaccine Preventable illnesses, the benefits of immunization may seem less important than the potential adverse effects.

Strategies for decision-making on vaccine use: the French experience

The French government launched a 5-year national program for improvement in vaccination policy in 2012 to simplify the guidelines, facilitate access to vaccination, invest in research and evaluate its vaccine policy.

[Immunizing is not only a children's matter! : Why vaccinations are also important for adults].

There is striking lack of data of adult vaccination rates and an international consensus regarding adult vaccination recommendations or guidelines are not available in Europe, and in only six countries a comprehensive document describing recommended vaccinations for adults is available.

Vaccination: the cornerstone of an efficient healthcare system

Overall, vaccination can still be regarded as one of the most cost-effective healthcare interventions, where only a few healthcare interventions are considered to be cost-saving.

Pneumococcal vaccination in autoimmune rheumatic diseases

A current review of PPV-23 and PCV-13 vaccines for specialists following patients with AIRD is provided, based on international and national vaccine guidelines.

From population to public institutions: what needs to be changed to benefit from the full value of vaccination

Government, international agencies, and other stakeholders have an important role to play to help society regain confidence in vaccination and ensure that the benefits of vaccination programmes are fully recognised and valued.

A scoping review of literature exploring factors affecting vaccine uptake within Roma communities across Europe

This study aims to identify barriers to Roma vaccination in general with a view to informing analysis of potential low levels of vaccination within Roma communities for COVID-19.

Measles among migrants in the European Union and the European Economic Area

It is essential that routine surveillance of measles cases and measles, mumps and rubella vaccination coverage become strengthened, to capture migrant-specific data, which can help to inform the provision of preventive services.



Measles in health-care settings.

Re-emergence of pertussis: what are the solutions?

Vaccination of newborns, additional booster doses for older adolescents and adults, and immunization of pregnant women with existing vaccines are discussed and their potential impact on pertussis control assessed.

Rationale for pertussis booster vaccination throughout life in Europe.

Resurgence of pertussis calls for re-evaluation of pertussis animal models

Pertussis has recently re-emerged in well-vaccinated populations most likely due to a combination of pathogen adaptation and waning of vaccine-induced pertussis immunity, and the scenario asks for new, improved vaccines with at least a longer duration of protection.

MMR vaccination and disease elimination: the Finnish experience

An overview of MMR vaccinations and the Finnish experience of the MMR disease elimination process is presented, and surveillance activities in the era following elimination in Finland are described.

The Global Pertussis Initiative: Meeting report from the fourth regional roundtable meeting, France, April 14-15, 2010

Despite the widespread availability of 2 classes of effective vaccines, whole cell and acellular, Bordetella pertussis infection remains a global epidemic. Pertussis is primarily a disease of

Vaccine-preventable Diseases

This chapter analyzes the costs and cost-effectiveness of scaling up the EPI and introducing selected new vaccines into the program. It also summarizes the epidemiology of diseases preventable

Challenges faced by the global polio eradication initiative

This editorial will provide an overview of the polio eradication strategies, progress to date, challenges and efforts to overcome those challenges that, although substantial, are surmountable.

Bordetella pertussis: why is it still circulating?

  • N. Guiso
  • Medicine
    The Journal of infection
  • 2014